AMETEK, Inc. $AME Shares Sold by Farmers & Merchants Investments Inc.

Farmers & Merchants Investments Inc. lessened its holdings in shares of AMETEK, Inc. (NYSE:AME - Free Report) by 8.5% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 32,808 shares of the technology company's stock after selling 3,048 shares during the quarter. Farmers & Merchants Investments Inc.'s holdings in AMETEK were worth $5,937,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. grew its position in shares of AMETEK by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 26,484,263 shares of the technology company's stock worth $4,559,001,000 after acquiring an additional 336,491 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of AMETEK by 21.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 10,970,047 shares of the technology company's stock worth $1,888,385,000 after acquiring an additional 1,908,742 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of AMETEK by 2.8% in the 1st quarter. JPMorgan Chase & Co. now owns 5,747,368 shares of the technology company's stock worth $989,352,000 after acquiring an additional 154,682 shares in the last quarter. Flossbach Von Storch SE grew its position in shares of AMETEK by 1.2% in the 1st quarter. Flossbach Von Storch SE now owns 3,770,066 shares of the technology company's stock worth $648,979,000 after acquiring an additional 45,714 shares in the last quarter. Finally, Invesco Ltd. grew its position in shares of AMETEK by 127.2% in the 1st quarter. Invesco Ltd. now owns 3,479,397 shares of the technology company's stock worth $598,943,000 after acquiring an additional 1,947,831 shares in the last quarter. Institutional investors and hedge funds own 87.43% of the company's stock.

AMETEK Stock Performance

Shares of AME stock opened at $187.81 on Monday. AMETEK, Inc. has a 1-year low of $145.02 and a 1-year high of $198.33. The company has a current ratio of 1.63, a quick ratio of 1.04 and a debt-to-equity ratio of 0.15. The company has a market capitalization of $43.38 billion, a price-to-earnings ratio of 30.24, a P/E/G ratio of 2.70 and a beta of 1.10. The stock's fifty day simple moving average is $183.88 and its 200-day simple moving average is $177.15.

AMETEK (NYSE:AME - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The technology company reported $1.78 earnings per share for the quarter, beating analysts' consensus estimates of $1.69 by $0.09. AMETEK had a return on equity of 16.53% and a net margin of 20.60%.The business had revenue of $1.78 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter in the previous year, the company posted $1.66 earnings per share. AMETEK's revenue for the quarter was up 2.5% compared to the same quarter last year. AMETEK has set its Q3 2025 guidance at 1.720-1.760 EPS. FY 2025 guidance at 7.060-7.200 EPS. On average, sell-side analysts predict that AMETEK, Inc. will post 7.15 earnings per share for the current fiscal year.

AMETEK Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Monday, September 15th will be paid a $0.31 dividend. The ex-dividend date is Monday, September 15th. This represents a $1.24 dividend on an annualized basis and a yield of 0.7%. AMETEK's payout ratio is 19.97%.

Wall Street Analysts Forecast Growth

AME has been the subject of several research reports. Barclays initiated coverage on AMETEK in a research report on Wednesday, September 10th. They issued an "equal weight" rating and a $200.00 target price for the company. KeyCorp boosted their price objective on AMETEK from $195.00 to $205.00 and gave the company an "overweight" rating in a research report on Friday, August 1st. Mizuho boosted their price objective on AMETEK from $212.00 to $225.00 and gave the company an "outperform" rating in a research report on Friday, August 1st. TD Cowen upgraded AMETEK from a "sell" rating to a "hold" rating and boosted their price objective for the company from $158.00 to $180.00 in a research report on Tuesday, September 2nd. Finally, Melius Research upgraded AMETEK to a "hold" rating in a research report on Monday, July 14th. Seven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $205.00.

About AMETEK

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.